University of Connecticut

OpenCommons@UConn
Master's Theses

University of Connecticut Graduate School

5-11-2013

Effects of a Hospital-Wide Quality Improvement
Initiative on 30-day Readmissions for Patients with
Heart Failure
Senthilraj Ganeshan
University of Connecticut, raj827@gmail.com

Raj Ganeshan
University of Connecticut, raj827@gmail.com

Recommended Citation
Ganeshan, Senthilraj and Ganeshan, Raj, "Effects of a Hospital-Wide Quality Improvement Initiative on 30-day Readmissions for
Patients with Heart Failure" (2013). Master's Theses. 426.
https://opencommons.uconn.edu/gs_theses/426

This work is brought to you for free and open access by the University of Connecticut Graduate School at OpenCommons@UConn. It has been
accepted for inclusion in Master's Theses by an authorized administrator of OpenCommons@UConn. For more information, please contact
opencommons@uconn.edu.

Effects of a Hospital-Wide Quality Improvement Initiative
on 30-day Readmissions for Patients with Heart Failure

Raj Ganeshan

B.S., University of Connecticut, 2009

A Thesis
Submitted in Partial Fulfillment of the
Requirements for the Degree of
Master of Public Health
at the
University of Connecticut
2013

APPROVAL PAGE

Master of Public Health Thesis

Effects of a Hospital-Wide Quality Improvement Initiative
on 30-day Readmissions for Patients with Heart Failure

Presented by

Raj Ganeshan, B.S.

Major Advisor ___________________________________________________________
Joan Segal

Associate Advisor ________________________________________________________
Jason Ryan

Associate Advisor_________________________________________________________
Joseph Burleson

University of Connecticut
2013
ii

Acknowledgements

I would like to express my appreciation to all those who provided me the possibility to complete
this report. A special thanks to Dr. Jason Ryan who has advised me on this project for three
years. He continually encouraged my excitement in regard to research and has showed me the
good that can arise from the study of public health and medicine together. In many ways he was
my motivation and without his persistent help this thesis would not have been possible.

I am thankful to my major advisor, Ms. Joan Segal whose suggestions and advice helped improve
this thesis dramatically. I am so glad to have worked with her and am grateful for her thorough
reviews of this work. She has been indescribably helpful to me. I would also like to thank Dr.
Joseph Burleson for his feedback, advice, enthusiasm and support.

Another special thanks to Dr. Sangwook Kang who I have worked very closely. He has been
instrumental in the successful completion of this research. He has guided and encouraged my
learning and has helped me to achieve a deep understanding of this research.

iii

Table of Contents

Acknowledgements

iii

Abstract

viii

Introduction

1

Overview

1

Risk Predictors

4

Efforts to Reduce Readmissions

8

Preventable Readmissions

11

Readmissions as a Measure of Quality of Health Care

14

Risk Standardized Readmission Rate

16

Hospital Readmissions Reduction Program

19

Methods
Setting

22

Patient Data Collection

22

Determination of Readmission Rate

23

Analysis

23

Description of Quality Improvement Initiative

24

Comparison of Eligible Discharges 2008 vs. 2011

26

Comparison of All-Cause Readmission 2008 vs. 2011

31

Comparison of Unplanned Readmissions 2008 vs. 2011

31

Comparison of Eligible Discharges, Unplanned
Readmissions and Not Readmitted Patients in 2008 and 2011

37

Changes in characteristics of Unplanned Readmissions
and Not Readmitted Patients in 2008 vs. 2011

43

Regression Analysis

43

Results

Discussion

46

iv

Conclusion

53

References

54

v

List of Tables and Figures

Figure 1. Hospital Readmission Reduction Program Penalties

21

Table 1. Demographic Variables from Eligible Discharges

26

Table 2. Heart Failure Disease Specific Variables

27

Table 3. Comparison of Admission and Discharge Days of Week
among Eligible Discharges

27

Table 4. Comorbidities of Eligible Discharges

27

Table 5. Admission Medications from Index Hospitalization among
Eligible Discharges

28

Table 6. Discharge Medications from Index Hospitalization among
Eligible Discharges

29

Table 7. Vital Signs on Admission among Eligible Discharges

29

Table 8. Laboratory Data on Admission among Eligible Discharges

30

Table 9. Discharge Destination after Index Hospitalization among
Eligible Discharges

30

Table 10. Follow Up Visits Among Eligible Discharges

31

Table 11. Readmissions among Eligible Discharges

31

Table 12. Demographic Variables of Readmitted Patients

31

Table 13. Heart Failure Disease Specific Variables of Readmitted Patients

32

Table 14. Time Related Factors of Readmission

32

Table 15. Comorbidities of Readmitted Patients

33

Table 16. Medications Upon Readmission

33

Table 17. Discharge Medications of Rehospitalized Patients

34

Table 18. Vital Signs on Readmission

35

Table 19. Laboratory Data on Readmission

35

Table 20. Discharge Destination after Index Hospitalization of
Readmitted Patients

35

vi

Table 21. Discharge Destination after Rehospitalization among
Readmitted Patients

36

Table 22. Follow Up Visits Among Readmitted Patients

36

Table 23. Demographic Variables: Eligible Discharges vs. Unplanned
Readmissions

37

Table 24. Heart Failure Disease Specific Variables: Eligible Discharges
vs. Unplanned Readmissions

38

Table 25. Length of Stay of Index Hospitalization

38

Table 26. Comorbidities of Eligible Discharges vs. Unplanned
Readmissions

39

Table 27. Index Admission Medications for Eligible Discharges vs.
Unplanned Readmissions

39

Table 28. Discharge Medications of Eligible Discharges vs. Unplanned
Readmissions

40

Table 29. Vital Signs of Eligible Discharges vs. Unplanned Readmissions

41

Table 30. Laboratory Data of Eligible Discharges vs. Unplanned
Readmissions

42

Table 31. Discharge Destination after Index Hospitalization of Eligible
Discharges vs. Unplanned Readmissions

42

Table 32. Follow up Visits of Eligible Discharges vs. Unplanned
Readmissions

43

Figure 2. Odds Ratio Estimates for 2008 and 2011 Readmission Predictors

45

Table 33. Odds Ratio Estimates for 2008 and 2011 Logistic Regression
Backward Elimination Method

45

vii

Abstract
BACKGROUND: As readmissions have commonly been attributed to quality of care, federal
law has required the Center for Medicare and Medicaid Services to implement a program
penalizing hospitals with 30-day Heart Failure (HF) readmissions in excess of the national
average. This has resulted in widespread implementation of hospital quality improvement (QI)
initiatives to reduce readmissions. Little data exists on the effects of hospital wide efforts to
reduce HF readmissions.
OBJECTIVES: To describe how a QI initiative aimed at reducing 30-day HF readmissions can
affect the overall HF patient population. To describe the factors that differed between readmitted
and non-readmitted patients before and after a QI initiative. To identify characteristics of patients
who are less likely to respond to a QI initiative and the significance of these characteristics. To
identify any changes to the major predictors of readmission after a QI initiative.
METHODS: All heart failure discharges from the year prior to (2008) and after (2011) full
implementation of a QI initiative were reviewed and data from the medical record were
abstracted. Analyses were performed comparing discharges between 2008 and 2011 for patients
with and without readmission to identify changes in the HF population. Sub-analyses of each
year were performed to determine factors associated with readmission in each year.
RESULTS: Compared with 2008, patients admitted for HF in 2011 had a 4% absolute increase
in ejection fraction, 13% more were on a beta blocker on admission, 12% less were on an
angiotensin receptor blocker, 9% less were on aldosterone. Significantly fewer patients admitted
in 2011 presented with hyponatremia (2.4% vs. 11.1%). Seven-day follow-up after discharge
occurred 2.5 times more frequently in 2011. Factors that differed between readmitted and not
readmitted patients changed after the QI initiative. In 2008 readmitted patients were more often
diabetic, on aldosterone at initial presentation, and were discharged to a SNF after index
hospitalization. In 2011 readmitted patients more often had dementia, a lower initial creatinine
(mean 1.37 vs. 1.63), and had more often had a 7-day follow-up visit. Patients readmitted despite
the QI initiative had received more follow up visits before readmission and were discharged on
viii

more medications (absolute increase in mean by 2 medications) after readmission in 2011. By
logistic regression, the variables most associated with readmission in 2008 were the number of
medications on initial admission, total outpatient visits 30-days after index discharge, discharge
destination, aldosterone on initial admission, and diabetes; in 2011 variables associated with
readmission were dementia and 7-day follow up visit.
CONCLUSIONS: Hospital wide QI initiatives can significantly decrease the rate of readmission
and lead to significant changes in the overall HF population. Factors associated with readmission
prior to a QI initiative may represent modifiable risks. This study showed that after a QI initiative
there may be fewer known variables associated with readmission as efforts from the initiative
may have successfully removed well-established factors from contributing to readmission.
Patients readmitted despite QI initiatives may be affected by more severe disease and readmission
in these patients may not be avoidable.

ix

Introduction
One in four patients hospitalized for heart failure are rehospitalized within thirty days of
discharge. This unacceptable rate of readmission has gained the attention of many hospitals,
researchers, and policy makers in attempts to create a solution to this problem. With changes to
federal law, hospitals across the United States are now reacting by implementing initiatives to
reduce rehospitalizations for heart failure patients. As there is little known about the effects that
these initiatives will have, this report will include an analysis on the changes in readmission rate
and patient characteristics among the heart failure population at a single institution after
implementation of a hospital-wide program aimed at reducing 30-day readmissions. A review of
the background surrounding this issue is provided below prior to this analysis.
Overview
Readmissions within 30 days after a hospitalization for Heart Failure (HF) occurred at a rate of
24.7% for Medicare patients discharged in 2008-2011.1 For patients discharged in 2003-2004,
this rate was 26.9%.2 Little improvement in readmission rates have been seen despite evidence
showing that many readmissions may be preventable. Hospital readmissions have been a target
of quality measurement and performance-based incentives as some readmissions are presumed to
be associated with substandard care, such as poor resolution of the main problem and inadequate
discharge planning, during the initial hospitalization.3,4 Furthermore, as many as 12% to 75% of
hospital readmissions have been prevented in controlled trials using quality improvement
interventions.4
Hospital readmissions were first described in the Medicare population over 25 years ago when a
review of discharges between 1974 and 1977 found a 22% readmission rate in the 60 day post
discharge period for all Medicare beneficiary hospitalizations.5 By 2003 this rate was 31.1%,
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reflecting a relative increase in the readmission rates over time, two-thirds (19.6%) of which
occurred in the first 30 days.2
The most frequent diagnosis at initial discharge that results in readmission is HF. A study in
1985 found that 36% of HF patients were readmitted within a 6 month period.6 From October 1
2003 to September 30 2004, 7.6% of all patients with 30-day readmissions had been initially
discharged with a diagnosis of HF.2 Moreover, HF was responsible for 20% more readmissions
in this time period than the second most frequent cause, pneumonia, which was the condition at
initial discharge for 6.3% of all readmissions.
In a 2008 report to Congress, the Medicare Payment Advisory Commission (MedPAC) regarded
the Medicare program as fiscally unsustainable over the long term.7 Readmission reductions
were a strong focus of the report to address this concern. A subsequent study found that in 2004
approximately $17.4 billion of the $102.6 billion in hospital payments from Medicare was spent
on readmissions for all conditions on index discharge.2

The Congressional Budget Office

estimates that Medicare spending for hospital inpatient care will reach $234.9 billion in 2019. 8
Because of the high costs and frequency of readmissions, reductions in their occurrence could
help address concerns over the escalating costs of healthcare and the difficulties in achieving cost
reductions.3
In addition, preventing readmissions has direct benefits for patients. Readmissions are potential
life threatening events and median survival has been shown to decrease progressively after each
hospitalization. The average hospital stay on readmission has been shown to be 13.2% longer
(0.6 days) than that of a patient with the same Diagnosis Related Group (DRG) who has not been
hospitalized in the previous six months.2 Controlled studies have found higher quality of life
scores among those not readmitted and evidence that many readmissions are preventable, thus
suggesting that decreased readmissions are an indicator of better quality of care.
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Much of the purpose behind identifying the proportion of avoidable readmissions has been to
determine the appropriateness of using readmissions as a measure of quality of care. For all
cause readmissions, one systematic review found that the median proportion of readmissions
deemed avoidable was 27.1%.9 However, it was also shown that among studies assessing the
proportion of avoidable readmissions, there was wide variability in the data which made for a
difficult assessment of the number of preventable readmissions. A prior analysis from MedPAC
reported that 76% of readmissions are preventable.10 Although the variation in estimates of this
proportion may reflect differences in the quality of care, it is also a result of subjective criteria
used to define an avoidable readmission.9 Nevertheless, if a high proportion of readmissions are
in fact avoidable, then there may be a strong association between readmission and quality of care.
However, this relationship would be weakened if the proportion was instead low, a phenomenon
which may be seen as hospital initiatives to reduce readmissions take effect.9
Most studies have included all diseases in their analyses and therefore the proportion of avoidable
readmissions specific to HF cannot be determined with certainty. Whether or not an actual
proportion is known, there is an accumulation of evidence that suggests that rates of readmission
can be improved.
Patients with HF are known to have a response to intensified care; and transitional care
interventions have shown decreased readmissions through several strategies, including
reengineered hospital discharge programs.11 Among HF patients readmitted within 30 days in
2003, 52% were found not to have had a visit to a physician’s office between discharge and
readmission.12,2 The wide variations in readmission rate among states also suggest that patients
with the same disease process may be more likely to be readmitted in one hospital system than
another and that there is room for improvement on a national scale.2
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With evidence supporting the ability to lower readmission rates, the Centers for Medicare and
Medicaid Services have implemented hospital penalties for readmissions. For patients with an
index admission of HF, pneumonia, and heart attack, all unplanned readmissions are analyzed to
determine hospital penalties. This initiative was the result of MedPAC recommendations and
policies from the Patient Protection and Affordable Care Act that took effect on October 1 2012.
About 67% of 3,282 hospitals studied will be penalized as a result of their readmission rates this
year. 13 To avoid penalties hospitals must try and prevent as many readmissions as possible and
most are implementing initiatives adopted from proven interventions which have lowered
readmissions in controlled trials.
Risk Predictors
To clarify the determinants and to be able to prevent readmissions, researchers have collected
considerable amounts of data from Medicare claims and retrospective reviews to identify risks
associated with increased likelihood of readmission. Patients with a prior hospitalization for HF
are most frequently readmitted for heart failure (37.0%), pneumonia (5.1%), renal failure (3.9%)
and nutrition-related or metabolic issues (3.1%).2

Acute myocardial infarction, chronic

obstructive pulmonary disease, arrhythmias, circulatory disorders, gastrointestinal bleeding, and
gastrointestinal problems make up 14.0% of readmission diagnoses. Other less frequent causes
comprise the remaining 36.9% of readmissions. It has also been estimated that after an index
hospitalization for heart failure, approximately 10% of readmissions are planned. Although
readmission diagnoses provide insight into the factors that result in readmission, Medicare
penalties do not depend on readmission diagnoses. Therefore, most data are focused on patient
and care-related factors at index admission that result in all cause readmissions.
One study found that the most influential factors associated with readmission include reason for
the index hospitalization (e.g., HF), the number of previous hospitalizations, and the length of
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stay; these had more influence on readmission than demographic factors.2 For example, three or
more readmissions in the prior six months led to a hazard ratio of 2.504 (95% CI 2.495-2.513);
for a single readmission alone the hazard ratio was 1.378 (95% CI 1.374-1.383). In comparison,
the risk of readmission related to age was greatest for those 85-89 years, with a hazard ratio of
1.123 (95% CI 1.111-1.136); although significant, the risk is much less than associated with
recent readmissions.
Validated readmission risk prediction models have been designed, each with unique
discriminative abilities. One of these, a multivariate model based on a retrospective review of
Medicare beneficiaries with heart failure in Connecticut hospitals, found that of 32 patient and
clinical factors, four were significant predictors of readmission in six months.14 These factors
included prior admission within one year, prior heart failure, diabetes and creatinine level
>2.5mg/dL (indicating renal disease) at discharge.14 While the validation cohort patients with 1-2
predictors had a 48% rate of readmissions, those with 3-4 predictors had a 59% rate of
readmission. This study pointed out the difficulty in identifying patients at low risk for all cause
readmissions since having no predictors still resulted in a 26% readmission rate.
When the same patient sample was used to analyze administrative data, important predictors were
identified including male gender, prior hospitalization, higher comorbidity score, treatment in a
tertiary care hospital and prolonged length of stay during the index hospitaliziton.15,16
A study using administrative records from a New York state research database on heart failure
patients found that more predictors could be identified if focus was geared only on readmissions
which were also for HF. This study similarly found that the comorbid illnesses, diabetes and
renal disease, were both predictors of readmission.16 Other predictors identified included black
race, Medicare insurance, Medicaid insurance, home health care services after discharge,
ischemic heart disease, valvular heart disease, chronic lung disease, idiopathic cardiomyopathy,
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prior cardiac surgery and use of telemetry monitoring during index hospitalization; these were all
labeled as higher risk predictors. Four lower risk predictors identified included treatment in a
rural hospital, discharge to a skilled nursing facility, performance of echocardiogram during the
index admission and performance of cardiac catheterization during the index admission. A
simple scoring system was then created by subtracting the number of lower risk predictors from
the number of higher risk predictors.

Lower risk predictors had the effect of reducing

readmission rates. A readmission rate of approximately 27% could be achieved by having 4
higher risk factors, or 7 higher risk factors and 3 lower risk factors. The regression model for
readmission with each patient’s simple risk score had a c statistic of 0.60 (p<.001), which
indicated modest predictive ability. Compared to the previous study, this study did not include
data on prior hospitalizations or heart failure history. Furthermore, except for chronic lung
disease, the predictors in this study were not included in the previous study. However, chronic
lung disease was not found to have a significant statistical relationship to readmission of HF
patients and was not included in the regression analysis.14
Data available in electronic medical records (EMRs) have been shown to have reasonable
predictive ability on 30-day readmission (C statistic 0.72) in another model.17 This model
combined both clinical and non-clinical factors found in the EMR. The Tabak mortality score
was integrated into the model for clinical variables, since it has been previously demonstrated to
perform modestly well in predicting readmission (c-statistic 0.61). The Tabak mortality score
includes age in addition to the worst value within the first 24 hours of hospital presentation for 17
laboratory and vital sign variables: albumin, total bilirubin, creatine kinase, creatinine, sodium,
blood urea nitrogen, partial pressure of carbon dioxide, white blood cell count, troponin-I,
glucose, internationalized normalized ratio, brain natriuretic peptide, pH, temperature, pulse,
diastolic blood pressure, and systolic blood pressure. Additional demographic, health behavior,
and healthcare utilization factors which were found to be significant predictors of readmission in
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the multivariate analysis included single status, male status, Medicare, number of home address
changes, history of depression or anxiety, history of confirmed cocaine use, number of prior
inpatient admissions, and presentation time between 6 AM – 6 PM. Weakly significant factors in
the multivariate analysis were residence in a census tract of the lowest socioeconomic quintile
(p=0.08), history of missed clinic visit (p=0.06), and use of a health system pharmacy (p=0.08),
were retained in the model for their conceptual significance. The addition of all of these variables
and the Tabak mortality score in the 30-day readmission prediction model produced a C-statistic
of 0.72, an increase from 0.61 for the Tabak mortality score alone. This model showed the utility
of including the social, behavioral, and economic circumstances of the patient when calculating
readmission risk. In addition, the variables used in this model were all found in the EMR which,
unlike claims data, is available early in the course of hospitalization and therefore is of more
practical use. Of note in this study, patients in the lowest risk group for readmission were
identified as having an 8-12% readmission rate. For Medicare beneficiaries alone the lowest risk
group may carry a risk greater than this value as they have been shown to have increased risk
over the general population.
Differences in risk factors arise when readmissions are examined at different time points. A
Swiss study found that hospital readmission or death at 90 days was best predicted by history of
coronary artery disease, prior MI, charlson score, elevated jugular venous pressure, lung rales,
prior abdominal surgery, age, and geriatric depression scale score; whereas at 30 days these
outcomes were best predicted by angina, lower systolic blood pressure, anemia, edema, higher
creatinine levels and dry cough.18
There are clearly several factors which influence readmission risk, some modifiable and others
not. Patient factors in the above mentioned studies were mostly of unmodifiable risk indicators,
typically due to comorbid illness. However, there may be other factors which were not included
in these studies which have better predictive ability. A systematic review of 117 studies found
7

that patient characteristics are weak predictors of readmission. 19 Furthermore, no consistent
predictors emerged from the review, although it did reveal significant heterogeneity among the
studies including such factors as follow up periods, which ranged from 14 days to 4 years. One
possibility from this data is that other patient and hospital factors may have more influence on
readmission risk.

Additionally, such factors, including education to improve compliance,

appropriate relay of information by hospitals to outpatient providers, and medical errors, may be
modifiable. These risk factors are central to efforts to reduce readmissions since they may be
both modifiable and contain a better ability to predict readmissions.
Efforts to Reduce Readmissions
A variety of unique approaches to prevent hospitalizations and subsequent readmissions have
been investigated. Outpatient disease management programs are among the earliest efforts to
show reductions in hospitalizations for HF. However, the generalizability of findings from these
interventions is difficult to determine as many different types of interventions have been tried.
Additionally, the evaluators and developers of these programs are often the same which has
raised questions about the validity of this evidence.28 Meta-analyses have grouped disease
management programs into three categories and suggest the following conclusions: (1) in-person
specialized multidisciplinary follow-up either at home or in clinic reduced HF hospitalizations
(RR 0.74) and all-cause hospitalizations (RR 0.81); (2) long-term patient self-care activities with
frequent reinforcement reduced HF hospitalizations (RR 0.44-0.66) and all-cause hospitalizations
(RR 0.59-0.80); and (3) studies that employed structured telephone support with a nurse reduced
HF hospitalizations (RR 0.75-0.78) but not all-cause hospitalizations.28 Of note, data on the
success of outpatient disease management programs are based on all HF hospitalizations over
different time periods, often 1 year, but do not provide information on the influence of these
programs specifically on 30-day HF readmissions. Additionally, large randomized clinical trials
of disease management programs including Medicare Health Support pilot programs and the
8

COACH trial found no benefit on readmission rates. However, both the Medicare and COACH
studies mentioned above were designed for care over a long term and neither was aimed
specifically at reducing 30-day readmissions.29,30
Telemonitoring disease management programs utilize methods including the remote intermittent
transmission of blood pressures and weight. Two large randomized trials have shown that as a
sole intervention, telemonitoring has no benefit on 6-month HF readmission.31,32 Data from
outpatient disease management programs therefore suggest that features of effective programs
include frequent in person contact with clinicians and formal self-care education and support
rather than telephone contact or telemonitoring alone.28
The focus of inpatient initiatives has been on adhering to evidenced based heart failure care such
as CORE measures, improving the discharge process, and ensuring a safer transition from
hospital to home through established early follow up appointments and timely communication
with outpatient physicians. Adherence to clinical process measures for inpatients with HF,
including prescribing an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker,
prescribing a beta blocker, providing smoking cessation counseling, and documenting the ejection
fraction, have been associated with small (0.2%) reductions in 30-day readmissions.33 Larger
reductions have been seen with transitional and coordinated care interventions.
A meta-analysis of discharge planning and post discharge support interventions found a
significant reduction in all-cause readmissions (RR 0.75).34 This involved readmissions which
occurred between 3-12 months after index discharge.

Interventions included medication

counseling, education, dietary counseling, social work consultations, home visits, telephone
follow-up, and more.

Despite the risk reduction, the intervention group still had a mean

readmission rate of 34.9%.

Still, the significant reduction supports the routine use of
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comprehensive discharge planning and post discharge support, although the analysis also shows
that additional measures are needed to reduce readmissions to a more acceptable rate.
Follow up with a physician within seven days after discharge to review medications, examine the
patient (including reassessment of fluid status), and provide patient education has been
recommended. A large study found that 7-day follow ups were associated with a 3% lower rate
of 30-day readmissions in some hospitals.35
Coordinated care models, which provide interdisciplinary care coordination to patients across
multiple settings and different degrees of ongoing support to implement a plan of care, have seen
positive results in readmission reductions. However, these were not geared only to patients with
HF.
The Transitional Care Model (TCM), Care Transitions Initiative (CTI), and Project RED share
four main components. They coordinate care between hospital and post-hospital providers,
educate patient and families, provide monitoring of a patient’s health status post-discharge, and
employ a coach or team to manage clinical, social, rehabilitative, nutritional, and pharmacy needs
after discharge.39
The TCM institutes a multidisciplinary team led by a transitional care nurse and targets high-risk
older adults.39,43 This model provides seven-days per-week telephone support along with regular
home visits. The duration of the intervention ranges from one to three months and subsequently
access to continuing services such as palliative care, hospice care, and chronic case management
is facilitated. A random controlled trial of HF patients showed that the intervention TCM group
had fewer readmissions in one year following discharge. Additionally, cost of care during the
year post-discharge was reduced by 39% per patient.43
In the CTI program a nurse transition coach saw the patient in the hospital to perform medication
reconciliation, provide education and ensure follow up plans.28,44 This transition coach then
10

visited the patient’s home during the 7-day post discharge period and made two phone calls
within 30-days after discharge. However, only 20% of the patients in the trial had HF; 30-day
readmission rates decreased from 11.9% to 8.3%, but it is difficult to determine the impact on HF
patients alone. The benefit of the CTI is that it is a low cost four-week program that can easily be
adopted by any hospital.
Project RED utilized a discharge advocate to coordinate discharge support and led to lower
combined hospital and ED utilization (incidence rate ratio 0.70).11,28

This model included

pharmacist medication reviews, which identified a number of medication errors and may have
contributed to the decrease in readmissions.

The proportion of patients with an index

hospitalization for HF was not provided.
A limitation of initiating these coordinated care models nationwide is that they are not always
cost effective.

For example, although one nurse-led program was able to reduce 30-day

readmissions by 48% for HF patients, there was little impact on direct costs to the healthcare
system in the 60 days following discharge.28,45 Additionally, it had a negative impact on hospital
revenue under the reimbursement system prior to the start of the Hospital Readmissions
Reduction Program.
Preventable Readmissions
For hospital planning it would be ideal to be able to predict the patients in which a 30-day
readmissions reduction initiative would be successful.

However, the evaluation of hospital

readmissions is complex because even with optimal care many readmissions are not preventable.
An understanding of risk factors helps identify patients likely to be readmitted but does not
necessarily identify those for whom readmission can be avoided. Moreover, there is no clear
understanding of whether early intervention is more efficacious in preventing readmission in
patients with numerous risk factors versus those with fewer. In some cases, early readmission
11

may be due to suboptimal care,9 whereas in other instances it results from a non-preventable
progression of the disease or from an entirely new disease process.4 As predictors of readmission
are established, it is critical that interventions designed to prevent readmission carefully consider
whether the risk indicators selected are indeed modifiable factors.4 Strong evidence for the
existence of modifiable risk factors is evidenced by geographic variability between states as rates
of readmission within 30 days after discharge are as low as 13.3% in some states and as high as
23.2% in others.2
The term potentially preventable readmission (PPR) was established to identify readmissions that
may have been prevented by the provision of quality care in the initial hospitalization, adequate
discharge planning, adequate post discharge follow up, or improved coordination between
inpatient and outpatient health care teams.20 To be considered a PPR, the readmission must be
clinically related to the index hospitalization. The authors conceptualize PPRs as fitting into one
of five categories, three of which are for medical readmissions: (1) a readmission for a
continuation or recurrence of the reason for the initial admissions or for a closely related
condition, (2) a readmission for an acute decompensation of a chronic problem that was not the
reason for the initial admission but was plausibly related to care either during or immediately
after the initial admission, (3) a readmission for an acute medical complication plausibly related
to care during the initial admission. Admissions that are excluded from being considered a PPR
which may occur in individuals admitted for HF include those associated with major or metastatic
malignancies, obstetrical admissions and admissions with a discharge status of left against
medical advice.

With these criteria in mind a panel of physicians examined all possible

admission and readmission combinations of the 314 All Patient Refined Diagnosis Related
Groups (DRGs) to determine whether two hospitalizations are clinically related. Using a Florida
inpatient hospital data source of 2005-2006 hospitalizations, the researchers reviewed 120,062
HF index admissions and 21,694 15-day readmissions, of which 14.4% were found to be
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unrelated to the index admission based on the readmission DRG and approximately 85.7% of
readmissions were considered a PPR. Although this method does identify some readmissions
which are not preventable, an accumulation of evidence suggests that far fewer than the 85.7% of
PPRs for HF are in fact preventable.
Most studies have used subjective criteria to determine whether readmissions are preventable,
resulting in the proportion of readmission determined to be avoidable to vary widely between
studies (5-79%, median 27.1).9 A meta-analysis determined that the most notable studies used
criteria with several qualifiers provided to define “avoidable”—along with multiple categories for
avoidable readmissions.9 Among these was a retrospective study of patients on a geriatric unit
with a readmission rate of 25%.21 A total of 48% of readmissions were deemed avoidable due to
inadequate medical management, social problems or inadequate rehabilitation. However, the
interval between index discharge and readmission was 12 months and only one reviewer was
used. Another study on 30-day readmissions found only 9% to be preventable, as determined by
three reviewers with strong inter-reviewer reliability (k=0.78, p<0.001).22

Reasons for

readmissions included medical system failures, an unfulfilled hope that the patient would improve
after discharge, or suboptimal judgments in evaluation or treatment.

Data from successful

interventions to reduce readmissions support the finding that some proportion of readmissions are
preventable, but more data is needed to understand the factors in an index hospitalization which
are associated with a preventable readmission.
Few studies have examined preventable readmissions in HF readmissions alone. A prospective
study of patients receiving home care services after a prior hospitalization with a primary or
secondary diagnosis of HF found that 73.3% of 90-day readmissions were not preventable.23 The
proportion of preventable readmissions in those with a primary HF diagnosis is not provided.
Additional limitations were that there was no mention of the reasoning behind labeling a
readmission as preventable and that preventability was based solely on the opinion of the treating
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home care nurse.

Another study of 90-day HF readmissions found that up to 50% were

preventable, 38% were possibly preventable and 15% were probably preventable.24 Subjective
assessment was used to determine the degree to which certain factors contributed to readmission
including noncompliance with medications (15%) or diet (18%), inadequate discharge planning
(15%) or follow up (20%), failed social support system (21%), and failure to seek medical
attention promptly when symptoms recurred (20%).
It has been shown that the proportion of readmissions deemed avoidable decreases significantly
with time from discharge.25 This suggests that readmissions occurring soon after discharge are
more likely to be avoidable than those which occur months to a year after discharge. It may also
explain some of the variation between the estimated proportions of avoidable readmission. A
meta-analysis from 2011 of 16 studies found that 23.1% of 30-day hospital readmissions were
classified as avoidable.26 Of the identified studies, none assessed avoidable readmissions in HF
patients alone. The weighted proportion of 23.1% may in fact in itself contain significant
variation depending on the number of days until readmission within the first month. An earlier
study classified 32% of readmissions occurring 0-6 days after discharge and only 6% occurring at
21-27 days as avoidable.27
Readmissions as a Measure of Quality of Health Care
The success of some transitional care interventions and improved discharge planning efforts
indicate that better care can decrease readmission rates. Furthermore, the presence of preventable
readmissions suggests that these readmissions may be associated with inappropriate care during
or after the index admission.4

This intuitive relationship between readmission rate and quality

of care has led to its use as a quality marker and as a basis for hospital reimbursement penalties.
In addition, the ease at which readmission data are available to payers such as Medicare has made
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their use appealing as a quality indicator. However the evidence linking readmission and quality
of care on initial hospitalization is mixed.
A retrospective study of patients at Veterans Affairs hospitals with HF and readmitted within 14days post discharge was performed reviewing quality measures at admission, during the course of
hospitalization, and at discharge.41 A significant association was found only with the quality of
care at discharge measured by a 10-point readiness for discharge score. This included the 10
following criteria: (1) Substantial improvement has occurred in symptoms and signs, (2) Weight
stable or decreasing, (3) Temperature less than 37.8 C for 24 hours, (4) Blood urea nitrogen and
serum creatinine stable or decreasing, (5) No cardiac medication changes for 24 hours, (6)
Digoxin level less than 2.6 nmol/L, (7) Prothrombin time stable, (8,9) Documentation that patient
or family understand the medication regimen and dietary regimen, (10) Plans for follow-up are
documented. A multivariate analysis of the readiness for discharge score derived from the
number of met criteria found that lower readiness for discharge scores were associated with a
higher risk for readmission after controlling for demographic and severity of illness variables.
Patients with one unmet criterion had an 18% increased odds of readmission.

However,

substandard care was defined by the authors as having a readiness for discharge score below the
25th percentile, which required more than three unmet criteria. Substandard care was responsible
for 18.5% of readmissions. The authors conclude that readmissions are therefore associated with
remediable deficiencies in the process of care, particularly the discharge process for patients with
HF.
Four out of five HF patients in this study were readmitted despite receiving the standard of care.
These findings more likely indicate that the association between substandard inpatient care and
early readmission are weak or that that the methods for measuring the quality of inpatient care
were inadequate.41
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A subsequent study was unable to prove the hypothesis that poor quality of care during a
hospitalization leads to increased readmission rates.42 Medicare claims data was used to create
and validate a model to predict readmission risk for HF patients which had a c-statistic of 0.56.
Data containing the results of quality reviews for Medicare inpatient hospitalizations examined by
a Medicare Peer Review Organization were obtained and the model was applied to these patients.
The resulting risk probabilities were used along with observed readmission outcomes to compare
risk-adjusted readmission rates for cases that had acceptable quality care ratings and for cases
whose quality of care was considered poor. There was no significant difference between the
observed to expected readmission risk ratio between those patients in the acceptable quality group
and those in the poor quality group for HF (p-value 0.252). Although the c statistic in this model
was low, it represents similar predictive ability as the model currently used by CMS (c statistic
0.60). Since the purpose of this study was to determine the validity of using readmission rates as a
measure of quality of care, for comparison it is beneficial that the model used in this study was
similar to the current model used to profile hospital performance.
Despite the fact that the literature appears to show that quality of care is weakly or not associated
with readmissions, a widely held opinion of the converse still persists. Although the validity of
readmission rates as an indicator of quality of care is uncertain, readmissions naturally raise
concern among health care providers and they endorse efforts to reduce readmissions..4 Still,
however, the lack of uniform findings of an association has led many to question the
appropriateness of measures to penalize hospitals based on high readmission rates.
Risk Standardized Readmission Rate
Medicare claims data have been used to create a readmission prediction model validated against a
medical record model containing clinical data, and this prediction model is now being utilized by
CMS to profile hospital performance.36 The purpose of the model is to account for differences
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across hospitals in patient demographic and clinical characteristics that might be related to
readmission but are unrelated to quality of care, a process known as risk adjustment or risk
standardization.37 This model was not devised to predict outcomes for individual patients, but
rather to identify high performing or low performing hospitals due to differences in quality or
other factors associated with various hospital systems. The predictive ability of the model for
individual patients is therefore modest, as established predictors of 30-day readmission such as
complications during hospitalization, patient race, socioeconomic status and discharge disposition
were excluded to avoid controlling for factors that can highlight important quality differences. 38
Risk Standardized Readmission Rates (RSRR) allow for a comparison of a particular hospital’s
performance given its case mix to an average hospital’s performance with the same case mix.
Hospitals that perform better than average can then be considered to be of better quality and those
with higher than expected readmissions are considered of worse quality.37
The model contains 37 variables which include 9 cardiovascular, 26 comorbidity and 2
demographic variables (age and sex). Claims data prior to the index hospitalization is required
for risk adjustment. CMS uses this model to calculate an excess readmission ratio, which is the
ratio of the predicted readmission rate to the expected readmission rate. Predicted readmissions
are those that occur within 30 days predicted on the basis of the hospital’s performance with its
observed case mix (determined by the hospital’s patient mix and its own hospital-specific
intercept as determined by the logistic regression model). Expected readmissions are those that
occur within 30 days and that are expected based on the nation’s performance with that hospital’s
case mix;37,1 they are determined by the hospital’s patient mix and the average hospital-specific
intercept based on all eligible hospitals.38 Excess readmission ratios are used to determine
payment adjustments for each eligible hospital.
The RSRR is the product of a hospital’s excess readmission ratio and the nationwide unadjusted
30-day readmission rate. Based on this rate, and the claims data used for adjustment, hospital
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performance is publicly reported on the hospital compare webpage (www.hospitalcompare.org)
and hospital reimbursement penalties are determined.1
Clinical data such as physiological data, laboratory results, and diagnostic test results are not
included in the current prediction model to standardize risk.38 One study found that adding
certain clinical variables to a claims-based model did not meaningfully change the ability of the
model to discriminate between high and low risk patients, improve concordance between
predicted probabilities and observed outcomes, or improve the model’s ability to account for
observed variance in the HF population. Clinical variables considered included ejection fraction,
heart rate, hemoglobin, serum creatinine, serum sodium, systolic blood pressure, and weight.
Among these only hemoglobin, serum creatinine, serum sodium and systolic blood pressure were
significantly related to readmission. However, including these variables with a claims-based
model had little effect on prediction of readmission. It is possible that this finding was due to the
ability of claims data to include patient level risk that is inherently contained in the claims data
and represented by the clinical data, or that the addition of these clinical data did not adequately
characterize patient level risk.38 The latter could be the result of the selection criteria for this
study. Although the selected variables represent multiple clinical domains, it is still possible that
other clinical variables may be of significance.
The current risk standardization method has been critiqued as it does not account for non-clinical
variables such as a patient’s support system or socioeconomic status (SES).13 This concern stems
from the belief that SES can affect a patient’s ability to eat properly, pay for medications, obtain
transportation to doctor appointments, and more, all of which can influence readmission status.
One study found evidence that major teaching hospitals and safety net hospitals were more likely
to have higher than predicted rates of readmission.13 The authors suggest that this finding may
relate to the fact that the risk standardization method used does not completely account for case
mix (medical complexity) and also excludes socioeconomic status. The authors themselves, in
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describing limitations of their study, note that there is no single method to determine which
hospitals care for the sickest patients or for more patients of low socioeconomic status.
Additionally, their conclusions are based on a single year’s predictions; further research is needed
to determine how well the current risk standardization model performs over time.

Hospital Readmissions Reduction Program
The Patient Protection and Affordable Care Act of 2010 (PPACA) implemented the Hospital
Readmissions Reduction Program, a Medicare program aimed at reducing hospital readmissions
through financial incentives. Through the program hospitals are penalized for readmissions in
excess of the national average for heart failure, acute myocardial infarction (AMI) and pneumonia
(PNA). The CMS risk standardization determines the average hospital performance with a given
hospital’s case mix. Hospitals with higher-than-predicted readmission rates are then penalized
based on their frequency of excess readmissions.
For example, a hospital with an expected HF 30-day risk standardized readmission rate of 25%
would be penalized based on the degree to which this rate was exceeded. If the hospital’s
readmission rate was 26% it would be 4% (1/25) over expected. The hospital would then be
assigned a penalty of 4% of all payments for HF hospitalizations. The maximum penalty allowed
under the HRRP is 1% of total Medicare reimbursements for fiscal year 2013, 2% in FY 2014 and
3% in subsequent years. If 25% of the hospital’s income was from HF, then this 4% can be
collected back by assigning a 1% penalty to all hospital payments. If the hospital made 12.5% of
its income from HF, then a 0.5% penalty for all hospital payments would result in the same fine
being collected. If the hospital made more than 25% of its income from HF, in this example the
hospital would not be penalized the full 4% of payments for HF, because this would require
greater than a 1% penalty to be applied to all hospital payments. Therefore, the 1% maximum
penalty would be applied. Similarly, if this hospital had a readmission rate greater than 26% and
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the hospital again made 25% of its income from HF, then a penalty greater than 1% would have
to be applied to all hospital payments; in this case, the maximum 1% penalty would apply again
regardless of the percentage of readmissions over expected.
The sum of all calculated penalties for HF, AMI, and PNA is used to determine whether a
hospital has exceeded the maximum penalty. Therefore, the previous example assumes that for
AMI and PNA there were no readmissions over expected.
As described in the example, the HRRP requires that all Medicare payments be reduced by a
percentage, which allows for a hospital to be fined the full penalty over a one-year period. If a
hospital’s calculated penalty is over the maximum allowed, then the hospital’s payments are
reduced by the capped maximum (i.e., 1% in 2013). The new payment structure as described in
the PPACA can be summarized as follows:


New payments to hospitals is an amount = (Base DRG payment) X (Adjustment factor)



Adjustment factor = Greater of A or B
(A) Ratio = 1 – (Aggregate Payments for excess readmissions / Aggregate payments for
all discharges)
(B) Floor adjustment Factor = .99 for 2013



Aggregate Payments for excess readmissions = (Base DRG Payment) x (Number of
Admissions) x (excess readmission ratio - 1) + X2 (AMI) + X3 (PNA)



Aggregate payments for all discharges = (Sum of all base DRG payments for all
conditions)



Excess Readmission Ratio = (risk adjusted readmissions) / (risk adjusted expected
readmissions)



Note: Excess readmissions do not include readmissions for which there are less than a
minimum number of discharges.
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In summary, for all hospital payments the base DRG amount will be multiplied by an adjustment
factor no less than 0.97 by FY 2015, which would result in a 3% maximum penalty. For a
hospital to be penalized less, base DRG payments for excess readmissions should be no more
than 3% of all base DRG payments in a given year. This can be depicted in Figure 1.

Figure 1. Hospital Readmission Reduction Program Penalties
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Note: X axis: Proportion of HF base DRG payments to sum of all base DRG payments. Y axis: Proportion over the
expected HF risk standardized readmission rate. Hospitals plotted on or above the line would receive the
maximum penalty. Those plotted below the line would receive a lesser penalty based on their readmission rate.
The example point (.25, .04) represents a hospital receiving 25% of its income from HF which is 4% over the
expected readmission rate (i.e., 26% RSRR with expected rate of 25%). This figure assumes zero excess
readmissions for Acute Myocardial Infarction or Pneumonia.
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Methods46, 47
Most methods used in this study are the same as those described in other studies 46,47 analyzing
this patient population and QI initiative; these have not yet been published.
Setting
The UConn Health Center’s John Dempsey Hospital is a 229-bed, acute-care hospital located in
Farmington, Connecticut. The hospital offers cardiac services including primary angioplasty and
cardiac surgery (not including heart transplant or left ventricular assist devices). Part of the
University of Connecticut Health Center, the hospital is largely staffed by salaried faculty
physicians as well as fellows, residents, and students. A small minority of patients receive care
from private practitioners.
Patient Data Collection
For the subset of patients readmitted to the UConn Health Center, demographic and clinical
variables were obtained through chart abstraction. A focused training session using an abstraction
tool designed for this study was provided prior to data collection. After the review of five sample
charts, results were compared to those of the primary investigator, Dr. Jason Ryan.

Any

discrepancies were addressed before proceeding to analyze additional patient charts. In order to
validate the interobserver agreement, a random sample of 10% of the records was reviewed
independently. For binary variables, data were compared with Cohen’s kappa coefficient.
Agreement is usually considered excellent for kappa >0.9 and very good for kappa 0.6 to 0.9. For
the majority of demographic variables, kappa was excellent at 1.0. The lowest kappa was 0.79.
For vital signs, interobserver agreement was 100%. For admission labs, agreement was 95%.
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Determination of Readmission Rate
The Connecticut Hospital Association (CHA) Chimedata database was used to determine 30-day
all-cause readmission rates.

This database contains all hospitalizations within the state of

Connecticut for all-payers. This allowed quantification of readmissions to our own institution as
well as other hospitals in Connecticut.
Patients were eligible if they were discharged from John Dempsey Hospital with a primary
diagnosis of heart failure during the pre-initiative period (January 1, 2008 through December 31,
2008) and the post-initiative period (January 1, 2011 through December 31, 2011). Patients were
considered to have a primary diagnosis of heart failure if the principle ICD-9-CM diagnosis code
for their admission was one of the following: 402.01, 402.11, 402.91, 404.01, 404.03, 404.11,
404.13, 404.91, 404.93, 428.0, 428.1, 428.20, 428.21, 428.22, 428.23, 428.30, 428.31, 428.32,
428.33, 428.40, 428.41, 428.42, 428.43, and 428.9. We excluded patients who were transferred to
another acute care hospital, who expired in the hospital, or who left against medical advice.
These are the same inclusions and exclusions used by the Centers for Medicaid and Medicare
Services (CMS) to determine readmission rates for the Hospital Compare website.

A

readmission was defined as a hospitalization for any reason within 30 days of discharge after the
index hospitalization. For patients with multiple readmissions during the 30-day window, only
the first readmission was counted, consistent with guidelines from CMS.
Analysis
Statistical analysis was performed using SAS 9.3 (Cary North Carolina). For continuous
variables, equality of the means was tested using a two-sample t-test assuming unequal variances.
For categorical variables, equality of the proportions was tested using a chi-square test. For data
elements with small sample sizes, p-values were obtained using the Fisher’s exact method.
Means and proportions for all variables were compared between readmitted and not readmitted
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patients and the p-values from this comparison were rank ordered prior to logistic regression. A
multivariate logistic regression was then performed independently for 2008 and 2011. Variables
with greater than 10% of missing data elements were removed prior to this analysis.

If

convergence criteria were not satisfied, then the variable with the largest rank ordered p-value
was removed and the model fitting was attempted again. This procedure was repeated until
convergence criteria were satisfied for both the 2008 and 2011 regression models. The remaining
variables were considered potential covariates, and variable selection was subsequently
performed with these covariates using a backward elimination regression method with
alpha=0.01.

Description of Quality Improvement Initiative
In 2009 the UCONN Health Center created the Heart Quality Team (HQT) to improve the
transition of care from the hospital to home and lower the 30-day all-cause readmission rate. The
HQT also joined a state-wide effort in February 2010 led by Qualidigm, the state’s Medicare
Quality Improvement Organization (QIO), and the CHA to reduce heart failure readmissions. As
part of this collaborative, HQT members attended seminars and received quarterly feedback on
the hospital’s progress in lowering rates of readmission.
The HQT identified hospitalized heart failure patients at JDH on a daily basis using a computergenerated list of inpatients receiving diuretics.6 This technique pared down the hospital
population to a manageable list of 20 to 30 patients who were likely to have heart failure. Charts
for each of these patients were reviewed to identify those individuals listed by a physician as
having a primary diagnosis of heart failure. A daily email of the entire hospital population of
heart failure patients was created to notify nurse managers, social workers, physicians, and other
key staff members.
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Targeted interventions to improve care were provided to each heart failure patient. Floor nurses
received specific training to provide heart failure teaching (low salt eating, daily weights,
medication compliance). A heart failure nurse practitioner evaluated many of the inpatients and
supplemented the HF education they were receiving from nurses. Staff members from nutrition,
pharmacy, and social work met with each patient. A 7-day follow-up appointment was scheduled
prior to discharge for most patients, often with the same physician or nurse practitioner who cared
for the patient in the hospital. For some weekend discharges, the follow-up appointment was
scheduled on Monday and the patient received a phone call for notification. Follow-up phone
calls were conducted 48 to 72 hours after discharge.
As part of the initiative, a team of community service providers that cared for the hospital patients
after discharge,

including skilled nursing facilities (SNFs) and visiting nurse associations

(VNAs), was formed. This team met monthly to discuss care transitions. Topics included
communication between community providers and physicians as well as standardized teaching
tools for heart failure education.
The HQT began its work in April of 2009. It took over a year to train nursing staff and engage
community providers. Mandatory 7-day follow-ups began in late 2010. Thus, 2008 represents the
last full calendar year prior to the program; 2011 represents the first full calendar year after its
complete implementation.
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Results
In the results data are compared between 2008 and 2011 patients to identify changes in the overall
Heart Failure patient population hospitalized at the UConn Health Center’s John Dempsey
Hospital. Additional comparisons are performed to identify differences between the 2008 and
2011 readmitted patients at their initial (index) hospitalization, which may exist due to the start of
the Quality Improvement Initiative between these years. Differences between readmitted patients
and not readmitted patients are used to identify variables which are associated with readmission;
to determine further whether these variables are independent of one another, results from a
backward elimination logistic regression analysis are shown below.
Comparison of Eligible Discharges in 2008 vs. 2011
The 2008 study sample contained 206 patients.
determined 189 to be eligible discharges.

The Connecticut Hospital Association

For 2011 these numbers were 224 and 209,

respectively. The mean age of eligible discharges was 80.5 in 2008 and 79.9 in 2011; 45% and
51.2%, respectively, were of male gender. There were no statistically significant differences in
these demographics (Table 1).
Table 1. Demographic Variables from Eligible Discharges
2008 (N=189) 2011 (N=209) P-Value
Age
80.5
79.9
0.633
Male (%) 45.0
51.2
0.215

Systolic heart failure was present in 51.1% of patients in 2008 and 48.8% in 2011, with the
remaining patients classified as having diastolic heart failure. A statistical difference was found
in ejection fraction, with a lower mean in those admitted in 2008 (Table 2).
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Table 2. Heart Failure Disease Specific Variables

Systolic HF (%)
Ejection Fraction

N
188
186

2008
51.1
42.7

N
208
208

2011
48.8
46.8

P-Value
.099
.029

The mean time of admission was 16:04 in 2008 and 20:24 in 2011, with no statistical difference
observed.

There were no statistical differences between admission or discharge days of week

between years (Table 3). The mean length of stay was longer in 2011, 5.3 vs. 4.6 days, although
this difference was not statistically significant (p=0.198).
Table 3. Comparison of Admission and Discharge Days of Week among Eligible Discharges
2008 (N=189)
Admission (%)
Sunday
16.4
Monday
12.7
Tuesday
15.9
Wednesday 16.9
Thursday
13.2
Friday
14.8
Saturday
10.1
P-Value=0.292

2011 (N=209)
Admission (%)
8.13
16.8
18.2
17.7
13.9
16.3
9.1

2008 (N=189)
Discharge (%)
13.2
19.1
13.8
17.5
13.2
15,3
7.9
P-Value=0.249

2011 (N=209)
Discharge (%)
8.1
16.8
18.2
17.7
13.9
16.3
9.1

The proportions of patients with certain comorbidities were similar in 2008 and 2011. Over
three-fourths of patients admitted had a prior history of heart failure in both years (Table 4).
Table 4. Comorbidities of Eligible Discharges
Diabetes Mellitus (%)
Dementia (%)
Prior Heart Failure
COPD (%)

2008 (N=189)
36.5
11.7
77.7
24.5

2011 (N=209)
34.5
10.1
82.8
18.2

P-Value
0.668
0.596
0.200
0.126

COPD= Chronic Obstructive Pulmonary Disease. N=188 for Dementia,
Prior Heart Failure and COPD in 2008; for all other values N is as specified.

The mean number of medications on admission was roughly 8.5 in both years (Table 5).
Significantly fewer patients with systolic HF in 2008 were admitted on a Beta Blocker.
Significantly more patients with diastolic HF in 2008 were admitted on an Angiotensin Receptor
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Blocker (ARB).

Significantly more patients in 2008 with systolic HF were admitted on

Aldosterone. Significantly more patients in 2008 were admitted on Coumadin. A non-significant
trend was observed with more patients in 2008 admitted on Digoxin.

Among patients on

Furosemide, 94 had a documented dosage in 2008, with a daily average of 57.7mg; in 2011, this
average was 55.9mg for 125 documented dosages. Admission medications were not documented
for 5 patients in 2008 and 3 patients in 2011.
Table 5. Admission Medications from Index Hospitalization among Eligible Discharges
2008 (N=184)
No. of Meds on Admission 8.6
Beta Blocker (%)
62.5
Beta Blocker (%)
54.8
Systolic HF
Beta Blocker (%)
70.0
Diastolic HF
ACE Inhibitor (%)
40.0
ARB (%)
24.5
ARB (%) Systolic HF
26.9
ARB (%) Diastolic HF
22.2
Aspirin (%)
54.9
Statin (%)
58.2
Digoxin (%)
20.1
Nitrate (%)
11.4
Aldosterone (%)
21.2
Aldosterone (%)
30.11
Systolic HF
Aldosterone (%)
12.2
Diastolic HF
Metolazone (%)
5.4
Coumadin (%)
37.0
Loop Diuretic (%)
71.3

2011 (N=206)
8.5
75.2
76.1

P-value
0.780
0.007
0.003

58.0

0.486

39.8
16.0
21.6
12.0
57.8
50.5
13.1
9.2
12.14
15.91

0.564
0.038
0.407
0.048
0.568
0.129
0.062
0.477
0.016
0.024

9.4

0.514

3.4
26.2
68.0

0.325
0.023
0.480

ACE= Angiotensin Converting Enzyme; ARB= Angiotensin Receptor Blocker.
N=181 for Loop Diuretic in 2008; for all other values N is as specified.

The mean number of medications on discharge was roughly 9 in both years (Table 6). Of note,
discharge medications were not documented for 17 patients in 2008; in 2011 only 3 patients did
not have documented medications at discharge. Proportions of patients discharged on the charted
medications were similar in both years with the exception of aldosterone, with significantly more
patients discharged on this drug in 2008; this relationship was the same as on admission. All
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other significant medication differences which existed on admission between years were not
significant upon discharge. The non-significant trend of more patients on digoxin in 2008 was
maintained at discharge.
Table 6. Discharge Medications from Index Hospitalization among Eligible Discharges
2008 (N=172)
No. of Meds on Discharge 8.8
Beta Blocker (%)
73.8
ACE Inhibitor (%)
41.0
ARB (%)
22.5
Aspirin (%)
65.9
Statin (%)
59.0
Digoxin (%)
17.9
Nitrate (%)
12.1
Aldosterone (%)
23.7
Metolazone (%)
5.2
Coumadin (%)
31.8
Loop Diuretic (%)
88.4

2011 (N=206)
9
79.6
44.9
17.0
68.0
57.3
11.2
8.7
12.1
4.9
30.1
86.9

P-value
0.559
0.184
0.453
0.174
0.670
0.742
0.061
0.278
0.003
0.877
0.722
0.664

ACE= Angiotensin Converting Enzyme; ARB= Angiotensin Receptor Blocker.
N=173 for all medications in 2008 except loop diuretic; for all other values
N is as specified.

Vital signs obtained on admission were similar in 2008 and 2011 (Table 7). Except for serum
sodium, laboratory data also were similar upon admission in the two years (Table 8). The mean
serum sodium value was lower in 2008, 136.4meq/L vs. 138meq/L in 2011; this difference was
statistically significant. Significantly more patients had serum sodium of less than 130meq/L on
admission in 2008.
Table 7. Vital Signs on Admission (Means) among Eligible Discharges
Systolic Blood Pressure (mmHg)
Diastolic Blood Pressure (mmHg)
Heart Rate (bpm)
Respiratory Rate (rpm)

N
188
188
187
179
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2008
137.5
73.1
84.5
23.0

N
195
195
196
192

2011
139.1
73.4
86.0
22.6

P-Value
0.585
0.870
0.508
0.611

Table 8. Laboratory Data on Admission among Eligible Discharges
Serum Sodium (meq/L)
Blood Urea Nitrogen (mg/dl)
Creatinine (mg/dl)
Glucose (mg/dl)
Hematocrit (%)
Serum Sodium < 130 (%)
Creatinine >1.5 (%)
Creatinine > 2.0 (%)

2008 (N=189)
136.4
30.7
1.55
146.9
35.0
11.1
31.8
14.3

2011 (N=208)
138.0
29.2
1.60
138.5
34.8
2.4
34.6
15.4

P-Value
<.001
0.436
0.635
0.184
0.658
<.001
0.545
0.759

For Hematocrit N=188 in 2008 and N=206 in 2011; for all other values N is
as specified. Hematocrit is described as the mean percentage; values for
Serum Sodium<130, Creatinine>1.5, and Creatinine>2.0 represent the
percentage of patients that met this criteria.

Proportions of patients discharged to destinations of home with no services, home with VNA
services and skilled nursing facilities were roughly even in 2008 (Table 9). In 2011 the largest
proportion of patients were discharged to skilled nursing facilities (37.9%), followed by home
with VNA services (33.3%) and home with no services (26.8%). Although this trend was seen in
2008, the differences were less noticeable. Few patients were discharged to hospice care in both
years. Discharge destination was not documented for 4 patients in 2008 and 11 patients in 2011.
A comparison of discharge destinations between years yielded no significant differences.
Table 9. Discharge Destination after Index Hospitalization among Eligible Discharges
Home no Services (%)
Home with VNA services (%)
Skilled Nursing Facility (%)
Hospice (%)

2008 (N=185)
31.9
33.0
33.5
1.6
P-Value=0.693

2011 (N=198)
26.8
33.3
37.9
1.9

The frequency of follow up visits after discharge increased significantly in 2011 compared to
2008. UConn follow up visits within 7 days of discharge increased from 19.6% in 2008 to 46.9%
in 2011. In 2011, significantly more patients had two or more UConn follow up visits in the 30day post discharge period, and significantly fewer patients had no UConn follow up during this
period (Table 10).
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Table 10. Follow Up Visits Among Eligible Discharges
0 outpatient visits 30-days (%)
1 outpatient visit 30-days (%)
2+ outpatient visits 30-days (%)
Mean outpatient visits 30-days
7 Day Follow Up UConn (%)

2008 (N=189)
52.8
19.4
27.2
1.0
19.6

2011 (N=209)
29.2
24.9
45.9
1.6
46.9

P-Value
<0.001
0.200
<0.001
<0.001
<0.001

Comparison of All-Cause Readmissions in 2008 vs. 2011
The 30-day all-cause hospital readmission rate decreased significantly from 25.4% (n=48) in
2008 to 18.2% (n=38) in 2011. In 2008 these included 4 planned readmissions, 40 unplanned
readmissions, and 4 readmissions to an outside institution. In 2011 these numbers were 3, 23, and
12, respectively (Table 11).
Table 11. Readmissions among Eligible Discharges
All Readmissions
UConn Unplanned Readmissions
Planned Readmissions
Outside Institution Readmissions

2008 (N=189)
48(25.4%)
40 (21.2%)
4 (2.1%)
4 (2.1%)

2011 (N=209)
38(18.2%)
23 (11.0%)
3 (1.4%)
12 (5.7%)

P-Value
0.040
<0.001
1.0

Comparison of Unplanned Readmissions 2008 vs. 2011
Among the 30-day all cause readmissions, 83.3% in 2008 and 60.5% in 2011 were unplanned
readmissions to UConn. The mean age of patients with unplanned readmissions was 81.4 in 2008
and 82.6 in 2011; 35% and 39.1%, respectively, were of male gender. There were no statistically
significant differences in these demographics (Table 12).
Table 12. Demographic Variables of Readmitted Patients
2008 (N=40) 2011 (N=23) P-Value
Age
81.4
82.6
0.665
Male (%) 35.0
39.1
0.743
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Systolic heart failure was present in 47.5% of patients with unplanned readmissions in 2008 and
47.8% in 2011; the rest of the patients were classified as having diastolic heart failure (Table 13).
A statistical difference was not observed in the mean left ventricular ejection fraction (LVEF) for
readmitted patients between years; however, as described above, a difference was observed in
mean LVEF between years for all discharged patients.
Table 13. Heart Failure Disease Specific Variables of Readmitted Patients
Systolic HF (%)
Ejection Fraction

N
40
37

2008
47.5
42.7

N
23
23

2011
47.8
46.5

P-Value
.980
.420

The mean time of index admission was 9:07 for unplanned readmissions in 2008 and 18:43 in
2011; this difference was not statistically significant.

The mean length of stay on index

admission was similar for both groups, 5.0 days in 2008 and 4.8 days in 2011. The mean number
of days between admission and readmission was 13.8 in 2008 and 14.9 in 2011 (Table 14).
Table 14. Time Related Factors of Readmissions
Sunday (%)
Monday (%)
Tuesday (%)
Wednesday (%)
Thursday (%)
Friday (%)
Saturday (%)
Length of Stay Index Hospitalization
Days until readmission

2008 (N=40)
17.5
12.5
17.5
22.5
15
10
5
5.0
13.8

2011 (N=23) P-Value
13.0
13.0
21.7
17.4
17.4
13.0
4.4
4.8
0.8376
14.9
0.5735

A significantly larger proportion of patients with unplanned readmissions had dementia in 2011
compared to 2008 (Table 15). The proportions of patients with the other charted comorbidities
were similar in both years among patients with unplanned readmissions. The index
hospitalization was the first episode of HF for only two readmitted patients in 2008 and one in
2011.
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Table 15. Comorbidities of Readmitted Patients
Diabetes Mellitus (%)
Dementia (%)
Prior Heart Failure (%)
COPD (%)

2008 (N=40)
50.0
12.5
95.0
20.0

2011 (N=23)
34.8
34.8
95.7
13.0

P-Value
0.242
0.035
1.0
0.484

COPD= Chronic Obstructive Pulmonary Disease. Prior Heart Failure
represents a history prior to the index admission.

The mean number of medications on readmission was 9.1 in 2008 and 9.7 in 2011; both means
were greater than the mean for all eligible discharges, which were roughly 8.5 in both years.
Moreover, no significant differences were observed in the proportion of patients on each of the
listed cardiac related medications between years (Table 16). There is a greater use of beta
blockers and ACE inhibitors in 2011 than in 2008, although not statistically significant, as well as
greater use of Coumadin. There was lower use of other drugs in 2011 than in 2008. Loop
diuretic usage included Furosemide, Bumetadine, Torsemide and Ethacrynic Acid; Furosemide
was most frequently observed. Among patients readmitted on Furosemide, 27 had a documented
dosage in 2008, with a daily average of 57.2mg; in 2011 this average was 74.2mg for 17
documented dosages. The difference between the two years was not statistically significant.
Table 16. Medications Upon Readmission
2008 (N=40)
No. of Meds on Admission 9.1
Beta Blocker (%)
77.5
ACE Inhibitor (%)
35.0
ARB (%)
32.5
Aspirin (%)
70.0
Statin (%)
72.5
Digoxin (%)
22.5
Nitrate (%)
7.5
Aldosterone (%)
37.5
Metolazone (%)
2.5
Coumadin (%)
30.0
Loop Diuretic (%)
77.5

2011 (N=23)
9.7
91.3
52.2
21.7
69.6
65.2
17.4
13.0
30.4
13.0
43.5
87.0

P-value
0.524
0.165
0.183
0.363
0.971
0.544
0.630
0.660
0.571
0.134
0.280
0.357

ACE= Angiotensin Converting Enzyme; ARB= Angiotensin Receptor Blocker.
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The mean number of medications upon rehospitalization discharge was significantly more in
2011, 10.6 vs. 8.6 (Table 17). A significantly larger proportion of rehospitalized patients were
discharged on an Angiotensin Converting Enzyme (ACE) Inhibitor in 2011 compared to 2008
(25.8% vs. 57.9). A non-significant trend was observed with rehospitalized patients discharged
less frequently on Aldosterone in 2011 (38.7% vs. 15.79%; p=0.086).

Proportions of

rehospitalized patients discharged on all other listed medications were similar in both years.
Among rehospitalized patients discharged on Furosemide, the most frequently observed loop
diuretic upon discharge, 24 had a documented dosage in 2008, with a daily average of 67.9mg,
compared to 53.6mg for 14 documented dosages in 2011, a difference that was not statistically
significant. Discharge medications were not documented for five patients in 2008; the remaining
differences in N are due to deaths prior to discharge.
Table 17. Discharge Medications of Rehospitalized Patients
No. of Meds on Discharge
Beta Blocker (%)
ACE Inhibitor (%)
ARB (%)
Aspirin (%)
Statin (%)
Digoxin (%)
Nitrate (%)
Aldosterone (%)
Metolazone (%)
Coumadin (%)
Loop Diuretic (%)

2008 (N=31)
8.6
74.2
25.8
32.3
58.1
70.1
29.0
9.7
38.7
9.7
27.6
83.9

2011 (N=19)
10.6
84.2
57.9
26.3
73.7
68.4
15.8
10.5
15.8
5.3
36.8
94.7

P-value
0.043
0.407
0.023
0.656
0.264
0.849
0.287
1.0
0.086
1.0
0.499
0.39

ACE= Angiotensin Converting Enzyme; ARB= Angiotensin Receptor Blocker.
For Coumadin in 2008 N=29; for all other values N is as specified.

Most vital signs obtained for unplanned readmissions were similar in both years (Table 18),
although respiratory rates were lower on presentation for 2011 readmissions. No statistically
significant differences in laboratory data were observed upon readmission between years (Table
19).

Although significantly lower serum sodium values were seen during the index

hospitalization in 2008 compared with 2011, they were not observed during the readmission.
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Table 18. Vital Signs on Readmission (Means)
Systolic Blood Pressure (mmHg)
Diastolic Blood Pressure (mmHg)
Heart Rate (bpm)
Respiratory Rate (rpm)

2008 (N=40)
123.7
64.3
87.6
21.8

2011 (N=23)
127.4
69.0
85.9
19.1

P-Value
0.655
0.331
0.780
0.030

For Respiratory Rate in 2008 N=39; for all other values N is as specified.

Table 19. Laboratory Data on Readmission
Serum Sodium (meq/L)
Blood Urea Nitrogen (mg/dl)
Creatinine (mg/dl)
Glucose (mg/dl)
Hematocrit (%)
Serum Sodium < 130 (%)
Creatinine >1.5 (%)
Creatinine > 2.0 (%)

2008 (N=40)
135.0
43.2
1.94
147.1
33.7
12.5
47.5
27.5

2011 (N=23)
136.7
35.8
1.62
162.7
33.6
4.35
34.8
17.4

P-Value
0.137
0.190
0.314
0.385
0.896
0.402
0.326
0.364

Hematocrit is described as the mean percentage; values for Serum
Sodium<130, Creatinine>1.5, and Creatinine>2.0 represent the percentage
of patients that met this criteria.

In 2008, most readmitted patients (50%) had been discharged to a skilled nursing facility after
their index hospitalization. In 2011, most readmitted patients (54.6%) had been discharged home
with VNA services. In both years discharge home with no services after index hospitalization
was least frequent among readmitted patients. No statistically significant differences in 2008 vs.
2011 discharge destinations for unplanned readmissions after index hospitalization were observed
(Table 20).
Table 20. Discharge Destination after Index Hospitalization of Readmitted Patients
2008 (N=40) 2011 (N=23)
Home no Services (%)
17.5
9.1
Home with VNA services (%) 32.5
54.6
Skilled Nursing Facility (%)
50.0
36.7
P-Value=0.2246
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A larger proportion of readmitted patients were discharged home with no services after
rehospitalization in 2008 than in 2011 (Table 21). The greatest proportions of rehospitalized
patients were discharged to a skilled nursing facility in 2008 and home with VNA services in
2011.

In 2008, 10% of rehospitalized patients were discharged to hospice, whereas no

rehospitalized patients were discharged to hospice in 2011. Finally, a larger proportion of patients
died during rehospitalization in 2011 compared to 2008.
Table 21. Discharge Destination after Rehospitalization among Readmitted Patients
2008 (N=40)
Home no Services (%)
22.5
Home with VNA services (%) 22.5
Skilled Nursing Facility (%)
35.0
Hospice (%)
10.0
Died (%)
10.0

2011 (N=23)
8.7
47.8
26.1
0
17.39

On average, unplanned readmissions received twice as much follow up prior to rehospitalization
in 2011 than in 2008 (1.1 days vs. 0.5 days). UConn follow up visits within seven days after
index discharge were significantly more frequent among 2011 readmissions (60.0% vs. 22.7%).
Significantly fewer patients in 2011 had no UConn outpatient follow up by the time of
readmission (30.4% vs. 65.8). Another trend observed, but not statistically significant, was that
more readmitted patients received seven-day follow up after rehospitalization in 2011 compared
to 2008 (Table 22).
Table 22. Follow Up Visits Among Readmitted Patients
0 outpatient visits until readmissions (%)
1 outpatient visit until readmission (%)
2+ outpatient visits until readmission (%)
Mean Number of Outpatient Visits
7 Day Follow Up UConn Index Admission
7 Day Follow Up UConn Readmission (%)

2008 (N=40)
65.8
23.7
10.5
0.5
22.7
32.3

36

2011 (N=23)
30.4
43.5
26.1
1.13
60.0
57.9

P-Value
0.008
0.106
0.112
0.012
0.022
0.062

Comparison of Eligible Discharges, Unplanned Readmissions and Not Readmitted Patients in
2008 and 2011
Eligible discharges contain the three subgroups of unplanned readmissions, not readmitted
patients and planned readmissions.

Unplanned readmissions are sometimes referred to as

readmitted patients in this section. Not readmitted patients in this analysis include those who
were not readmitted as well as any readmissions to an outside institution. As previously stated,
the majority of all readmissions are unplanned. P-values measure differences between unplanned
readmissions and not readmitted patients (planned readmissions were excluded). All means and
proportions presented are in reference to data obtained from the index hospitalization; that is, data
representing patients with unplanned readmissions are from the hospitalization prior to the
readmission occurring. Means and/or proportions for not readmitted patients are not provided
below.
Readmitted patients in 2008 were 0.9 years older on average than all eligible discharges; in 2011,
readmitted patients were 2.7 years older on average (Table 23). This difference was relatively
more significant in 2011 than 2008 (p= 0.197 vs. 0.610). There were also fewer male than female
readmissions in both years, and the difference was similarly significant in both years (p= 0.074
vs. 0.095).
Table 13. Demographic Variables: Eligible Discharge (ED) vs. Unplanned Readmission
(UR)
2008 (N=189) 2008 (N=40) P-Value 2011 (N=209) 2011 (N=23) P-Value
ED
UR
ED
UR
Age
80.5
81.4
0.610
79.9
82.6
0.197
Male (%) 45.0
35.0
0.074
51.2
39.1
0.095

Eligible discharges and unplanned readmissions had a similar proportion of systolic heart failure
in 2008 and in 2011. This similarity was also observed with ejection fraction. Among eligible
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discharges, no significant differences in either variable were observed between not readmitted
and readmitted patients in either year (Table 24).
Table 14. Heart Failure Disease Specific Variables: Eligible Discharge (ED) vs. Unplanned
Readmission (UR)
Systolic
HF (%)
Ejection
Fraction

2008 ED
51.1

2008 UR
47.5

P-Value
0.838

2011 ED
48.8

2011 UR
47.8

P-Value
0.411

42.7

42.7

0.875

46.8

46.5

0.884

For Systolic HF in 2008, N=188 for Eligible Discharges and N=40 for UR; for Ejection Fraction in 2008,
N=186 for Eligible Discharges and N=37 for UR; for 2011 Eligible Discharges and UR, N=208 and 23
respectively for both variables.

The mean length of stay on index admission was within 0.5 days comparing eligible discharges
and unplanned readmission; this was the case in both 2008 and 2011 (Table 25).
Table 15. Length of Stay of Index Hospitalization

Length of Stay Index
Hospitalization

2008 ED
(N=189)
4.6

2008 UR
(N=40)
5.0

Pvalue
0.463

2011 ED
(N=209)
5.3

2011 UR
(N=23)
4.8

PValue
0.412

Diabetes was more prevalent among readmitted patients in 2008 than among all eligible
discharges. This difference is attributable to more patients with an unplanned readmission having
diabetes than those not readmitted (p=0.046).

This difference was not observed among

readmissions in 2011. Dementia was more prevalent among readmitted patients in 2011 than
among all eligible discharges; this difference was also attributable to more patients with an
unplanned readmission having dementia than those not readmitted (p<0.001). This was not
observed in 2008. The index hospitalization was the first episode of HF for 95% of readmitted
patients in 2008 and 99.7% in 2011, vs. 77.7% and 82.8% among eligible discharges in respective
years. However, no statistical difference was observed between unplanned readmissions and. not
readmitted patients in either year for prior history of heart failure (Table 26).
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Table 16. Comorbidities of Eligible Discharges (ED) vs. Unplanned Readmission (UR)
2008 ED
(N=189)

Diabetes Mellitus
36.5
(%)
Dementia (%)
11.7
Prior Heart
77.7
Failure (%)
COPD (%)
24.5

2008 UR
(N=40)

PValue

2011 ED
(N=209)

2011 UR
(N=23)

PValue

50%

0.046

34.5

34.8

0.972

12.5
95

0.137
0.649

10.1
82.8

34.8
95.7

<0.001
0.574

20

0.359

18.2

13.0

0.498

COPD= Chronic Obstructive Pulmonary Disease. Prior Heart Failure represents a history prior to the index
admission.

On index admission readmitted patients were on more medications on average than eligible
discharges (0.5 medications more in 2008 and 1.2 medications more in 2011). However, no
statistically significant difference was observed for medication number on admission between
readmitted and not readmitted patients (p= 0.878, 2008; p=0.972, 2011). In 2008 more patients
with unplanned readmissions were on aldosterone at the time of their index admission compared
to all eligible discharges. This difference was due to significantly more readmitted patients than
not readmitted patients on aldosterone at index admission (p=0.003). No other statistically
significant differences were observed between readmitted and not readmitted patients for
admission medications (Table 27).
Table 17. Index Admission Medications for Eligible Discharges (ED) vs. Unplanned
Readmissions (UR)

No. of Meds on Admission

Beta Blocker (%)
ACE Inhibitor (%)
ARB (%)
Aspirin (%)
Statin (%)
Digoxin (%)
Nitrate (%)
Aldosterone (%)
Metolazone (%)
Coumadin (%)
Loop Diuretic (%)

2008 (N=184)
ED

2008 (N=40)
UR

P-Value

2011 (N=206)
ED

2011 (N=23)
UR

P-Value

8.6
62.5
40.0
24.5
54.9
58.2
20.1
11.4
21.2
5.4
37.0
71.3

9.1
66.7
33.3
33.3
59.0
66.7
23.1
15.4
38.5
2.6
28.2
63.2

0.878
0.545
0.598
0.146
0.564
0.225
0.602
0.380
0.003
0.373
0.202
0.214

8.5
75.2
39.8
16.0
57.8
50.5
13.1
9.2
12.14
3.4
26.2
68.0

9.7
73.9
47.8
17.4
56.5
60.9
21.7
8.7
8.7
4.4
30.4
65.2

0.972
0.875
0.404
0.849
0.898
0.291
0.193
0.926
0.592
0.790
0.625
0.765

ACE= Angiotensin Converting Enzyme; ARB= Angiotensin Receptor Blocker. N=181 for Loop Diuretic in
2008; for all other values N is as specified.
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The mean number of medications upon discharge in 2011 was greater for readmitted patients by
an absolute difference of 1.6 medications compared to eligible discharges. This difference was
not due to a statistically significant difference in medication number between readmitted and not
readmitted patients. No statistically significant discharge medication differences were observed
from the index hospitalization between readmitted and not readmitted patients in either year
(Table 28).
Table 18. Discharge Medications of Eligible Discharges (ED) vs. Unplanned Readmissions
(UR)
2008 ED
(N=172)

No. of Meds on Discharge

Beta Blocker (%)
ACE Inhibitor (%)
ARB (%)
Aspirin (%)
Statin (%)
Digoxin (%)
Nitrate (%)
Aldosterone (%)
Metolazone (%)
Coumadin (%)
Loop Diuretic (%)

8.8
73.8
41.0
22.5
65.9
59.0
17.9
12.1
23.7
5.2
31.8
88.4

2008 UR
(N=40)

8.6
77.5
37.5
32.5
75.0
70.0
17.5
15.0
32.5
5.0
27.5
87.2

PValue

0.437
0.547
0.604
0.086
0.167
0.106
0.937
0.527
0.136
0.948
0.506
0.792

2011 ED
(N=206)

9
79.6
44.9
17.0
68.0
57.3
11.2
8.7
12.1
4.9
30.1
86.9

2011 UR
(N=19)

10.6
82.6
56.5
17.4
60.9
69.6
13.0
8.7
17.4
4.4
34.8
91.3

PValue

0.610
0.705
0.234
0.957
0.439
0.206
0.762
0.994
0.413
0.905
0.603
0.506

ACE= Angiotensin Converting Enzyme; ARB= Angiotensin Receptor Blocker. For 2008 Eligible
Discharges N=173 for all medications except Loop Diuretic. For 2008 Unplanned Readmissions N=39 for
Loop Diuretic; for all other values N is as specified.

The mean systolic blood pressure was 5.4mmHg higher in 2008 for unplanned readmissions
compared to eligible discharges. In 2011 this difference was only 1.7mmHg. Although the
differences between systolic blood pressures for readmitted vs. not readmitted patients were
relatively more significant in 2008, no statistically significant differences were observed in either
year (p=0.265, 2008; p=0.716, 2009).

Other vital signs were similar among unplanned

readmissions and eligible discharges in both years (Table 29).
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Table 19. Vital Signs (Means) of Eligible Discharges (ED) vs. Unplanned Readmissions (UR)
2008 ED
(N=188)
Systolic Blood Pressure
(mmHg)
Diastolic Blood Pressure
(mmHg)
Heart Rate (bpm)

2008 UR
(N=40)

PValue

2011 ED
(N=195)

2011 UR
(N=21)

PValue

137.5

142.9

0.265

139.1

140.8

0.716

73.1

74.8

0.446

73.4

70.3

0.206

84.5
88.1
0.283
86
89.2
0.466
Respiratory Rate (rpm)
23.0
23.4
0.676
22.6
22.3
0.819
For 2008 Eligible Discharges N=187 for Heart Rate and N=179 for Respiratory Rate, for 2011 Eligible
Discharges N=196 and 192 respectively for these variables. For 2008 Unplanned Readmissions N=39 for
Respiratory Rate; for all other values N is as specified.

Table 30 below compares the laboratory data for both eligible discharges and unplanned
readmissions.

The mean creatinine was 1.37 for readmitted patients and 1.60 for eligible

discharges in 2011. This difference was due to a statistically significant difference between
readmitted and not readmitted patients (p=0.049). No such difference was observed in 2008 for
creatinine. In 2011 creatinine levels greater than 1.5 or 2.0 were less frequent among unplanned
readmissions than among eligible discharges. In 2008, these levels were more frequent among
unplanned readmissions. Differences between creatinine levels greater than 1.5 or 2.0 were
relatively more significant in 2011 than in 2008 for readmitted vs. not readmitted patients, but did
not reach statistical significance. The proportion of unplanned readmissions with a serum sodium
level less than 130 was 3.6 times that of eligible discharges in 2011; in 2008 this proportion was
only 1.1 times that of eligible discharges. The relative significance of a serum sodium level less
than 130 was greater in 2011 for readmitted vs. not readmitted patients (p=0.095) compared to
2008 (p=0.753). However, these differences did not reach statistical significance in either year.
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Table 20. Laboratory Data of Eligible Discharges (ED) vs. Unplanned Readmissions (UR)
2008 ED
(N=189)

2008 UR
(N=40)

PValue

2011 ED
(N=208)

2011 UR
(N=23)

PValue

Serum Sodium (meq/L) 136.4
135.7
0.323 138
136.5
0.155
Blood Urea Nitrogen 30.7
34.0
0.297 29.2
26.6
0.321
(mg/dl)
Creatinine (mg/dl)
1.55
1.73
0.401 1.60
1.37
0.049
Glucose (mg/dl)
146.9
153.9
0.489 138.5
142.8
0.746
Hematocrit (%)
35.0
34.27
0.278 34.8
33.1
0.093
Serum Sodium < 130 11.1
12.5
0.753 2.4
8.7
0.095
(%)
Creatinine >1.5 (%)
31.8
35.0
0.619 34.6
21.7
0.169
Creatinine > 2.0 (%)
14.3
17.5
0.513 15.4
4.4
0.120
For Eligible Discharges, N=188 for Hematocrit in 2008 and N=206 in 2011; for all other values N is as
specified. Hematocrit is described as the mean percentage; values for Serum Sodium<130, Creatinine>1.5,
and Creatinine>2.0 represent the percentage of patients that met this criteria.

As shown in Table 31, a smaller proportion of readmitted patients had been discharged home with
no services than eligible discharges (17.5% vs. 31.9%) in 2008; a larger proportion of readmitted
patients had been discharged to a skilled nursing facility (50.0% vs. 33.5%). Both eligible
discharges and unplanned readmissions had similar rates of discharge to home with VNA services
in 2008 (33.0 and 32.5, respectively). Discharge destinations after initial hospitalization were
significantly different between readmitted and not readmitted patients in 2008. In 2011, a smaller
proportion of readmitted patients had also been discharged home with no services compared with
eligible discharges (9.1% vs. 26.8%); a larger proportion of readmitted patients had been
discharged home with VNA services (54.6% vs. 33.3%).

Table 21. Discharge Destination after Index Hospitalization of Eligible Discharges (ED) vs.
Unplanned Readmissions (UR)

Home no Services (%)
Home with VNA services (%)
Skilled Nursing Facility (%)

Hospice (%)

2008 ED
(N=185)
31.9
33.0
33.5
1.6
P=0.004

2008 UR
(N=40)
17.5
32.5
50.0
0
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2011 ED
(N=198)
26.8
33.3
37.9
1.9

2011 UR
(N=23)
9.1
54.6
36.7
0

A similar proportion of eligible discharges and unplanned readmissions had a 7-day UConn
follow up visit after discharge in 2008 (Table 32). No significant difference in the frequency of
7-day follow up visits existed between readmitted and not readmitted patients in 2008. In 2011,
readmitted patients were more likely to have had a 7-day follow up than not readmitted patients
(p=0.006).
Table 22. Follow up Visits of Eligible Discharges (ED) vs. Unplanned Readmissions (UR)
2008 ED
(N=189)

7-Day Follow Up UConn 19.6
Index Admission

2008 UR
(N=40)

22.7

PValue

0.108

2011 ED
(N=209)

46.9

2011 UR
(N=23)

60.0

PValue

0.006

Changes in characteristics of Unplanned Readmissions and Not Readmitted Patients in 2008
vs. 2011
As stated in the previous comparison, not readmitted patients include any planned readmissions
and readmissions to an outside institution.

As in the previous section, p-values compare

differences between unplanned readmissions (readmitted) and not readmitted patients.
The comparison of readmitted and not readmitted patients in 2008 found that significantly more
readmitted patients were on aldosterone on index admission (p=0.003), were diabetic (p=0.046)
and were discharged with more services, either home with VNA services or to a skilled nursing
facility after index hospitalization (p=0.004).

These variables did not have a statistically

significant difference in 2011.
In 2011 more readmitted patients had dementia (p<0.001), a 7-day UConn follow up visit
(p=0.006), and a lower mean creatinine (p=0.049) than not readmitted patients.
Regression Analysis
Prior to performing logistic regression planned readmissions were removed. The 2008 maximum
regression model satisfied convergence criteria after the removal of all variables with greater than
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10% missing data, which only required the removal of variables with loop diuretic dosages. The
2011 maximum regression model satisfied convergence criteria after removing variables with
10% missing data and subsequently several variables by order of least significance from the
comparison of readmitted vs. not readmitted patients in the above section. The 2011 maximum
regression model contained only the following variables: age, gender, dementia (history of),
serum sodium, serum sodium less than 130meq/L, creatinine, creatinine greater than 1.5,
creatinine greater than 2.0, hematocrit, total outpatient visits 30-days after discharge and 7-day
follow up after index admission.
A subsequent variable selection procedure was performed using a logistic regression backward
elimination method. The backward elimination alpha was set at 0.01. The variables remaining in
the regression model for 2008 include the number of medications on admission, total outpatient
visits 30-days after discharge, gender, discharge destination, presence of Aldosterone on
admission, presence of an Angiotensin Receptor Blocker (ARB) on admission, presence of
Nitrate on discharge, creatinine greater than 1.5, history of Congestive Heart Failure (CHF),
history of Chronic Obstructive Pulmonary Disease (COPD), and history of Diabetes Mellitus
(DM). The variables remaining in the 2011 regression model after backward elimination were 7day follow up visit after index admission and history of dementia. In the 2008 model some of the
remaining variables were only marginally significant and did not reach full statistical
significance. Odds ratios and p-values are provided below in Figure 2 and Table 33.
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Figure 2. Odds Ratio Estimates for 2008 and 2011 Readmission Predictors
Odds Ratio Estimates for 2008 and 2011
Readmission Predictors

2008

2011

7-day Follow Up
Dementia
Diabetes Mellitus
Aldosterone (on admission)
Discharge Destination
Outpatient visits 30-days
No of admission meds
0

2

4

6

8

10

Note: Odds ratio estimates for 2008 and 2011 representing the likelihood of readmission,
determined using backward elimination logistic regression with elimination alpha=0.01.
Variables shown represent remaining covariates in final model with p-value<0.05.

Table 23. Odds Ratio Estimates for 2008 and 2011 Logistic Regression Backward
Elimination Method
2008

Odds Ratio P-Value

No. of Meds on admission
0.789
0.008
Total Outpatient Visits 30-days 1.646
0.007
Gender
0.404
0.087
Discharge Destination
4.537
<0.001
Aldosterone (on admission)
3.859
0.017
ARB (on admission)
2.898
0.057
Nitrate (on discharge)
4.017
0.062
Creatinine > 1.5
2.559
0.087
CHF
0.338
0.059
COPD
3.067
0.055
DM
3.896
0.010
2011
Dementia
8.291
<0.001
7-day follow up visit
4.879
0.004
Note: All variables refer to the index admission.
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Discussion
This paper describes a study of the UConn Health Center’s hospital-wide quality improvement
initiative. No similar report documenting the effects of this type of initiative was found on
literature review. A number of differences in patient characteristics were found when comparing
data before and after the initiative.

Although many of these differences were statistically

significant, they were not clinically significant but rather may have occurred due to random
variation. The most striking difference was an improvement in the outpatient follow up of
patients after discharge in 2011. The magnitude of the improvement in follow up makes it likely
that this was directly related to the QI initiative.
Full implementation of the initiative was completed by the end of 2010. The 2011 readmission
rate represents a 30% reduction in HF readmissions from 2008, the year prior to the start of the
initiative. Since the data used in this study are from the years immediately prior to and after
implementation, the improvement in readmission rate is likely attributable to the components of
this initiative. The initiative included identification of inpatients with HF; patient education
through multimedia and specially trained nurses; inpatient consultation by a HF nurse
practitioner, pharmacist, social worker, and dietician; follow up phone calls; 7-day follow up
appointments; development of

partnerships with referral centers in the community (SNFs,

VNAs); and multilingual support. It is not possible to tell which among these components were
most influential as all were in full effect by 2011. Previous studies have shown that components
of this initiative are successful in preventing readmissions but there is limited data demonstrating
the expectations of hospital-wide quality improvement on 30-day HF readmissions.
Compared to patients initially admitted in 2008, patients admitted in 2011 were less often
hyponatremic and had a higher mean ejection fraction (absolute increase of 4%).

These

differences were minimal and are unlikely to have been related to the QI initiative. It is more
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likely that they occurred due to random variation. Furthermore, when serum sodium level and
ejection fraction in patients who were readmitted were compared to the same variables in patients
not readmitted, a significant difference was not found in either year, indicating that these
differences were unlikely to have contributed to the lower readmission rate.
The most evident change which can be attributed to the QI initiative is the increased frequency of
follow up. The extent of this increase was greater than any other observed difference between
2008 and 2011 patients. Mean outpatient follow up visits in the 30-day after discharge period
increased by 60%. Readmitted patients had a 126% increase in mean 30-day outpatient follow up
visits after the initiative which, although not studied, may be influential in preventing a
subsequent readmission. Patients were approximately 2.5 times more likely to have a 7-day
follow up visit, and the chance of having two or more follow up visits in 30 days increased by
nearly 70%. The proportion of patients with no follow-up prior to readmission decreased by over
50%. These results suggest that follow up, and potentially other components of the initiative,
were likely the strongest contributors to the lower readmission rate.
Results from the regression analysis indicate that patients readmitted in 2011 were more likely to
have had a 7-day follow-up visit than not readmitted patients. Although this may seem as if
follow-up in 2011 was a risk predictor, it should be interpreted as having occurred more
frequently after initial admission among readmitted patients in 2011. This analysis did not
account for the overall increase in follow-up in all 2011 patients and this finding may therefore
undermine the importance of follow-up visits. The rate of 7-day follow up among not readmitted
patients was 19% (28 patients) in 2008 and 46% (84 patients) in 2011 which likely played an
important role in preventing readmission in these patients.
Improvements in the rates of follow up were most likely an important contributor to the lower
readmission rate but they are also easy to quantify compared to other parts of this initiative. It
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should be noted that this initiative involved several other components; although follow up visits
are a critical part of the QI initiative, a 30% reduction in hospital readmission rate is more likely
to be achievable by the implementation of a multicomponent QI initiative.
Several patients admitted to the UConn Health Center with HF were seen by outpatient providers
at the institution and some data indicate that the QI initiative may have had spillover effects on
outpatient care. Patients in 2011 with systolic HF were more likely to be on a beta-blocker at
their initial hospitalization and less likely to be on aldosterone. Beta blockers have proven benefit
in all patients with systolic HF whereas aldosterone is indicated in only some HF patients based
on their functional limitation and ejection fraction. Fewer patients with diastolic HF admitted in
2011 were on an angiotensin receptor blocker (ARB) compared to 2008.

Although

this

medication has proven benefit in systolic HF, it does not have a clear indication in diastolic HF.
The fact that these medication differences were specific to HF type makes it less likely that they
were due to random variation alone. It is possible that these medication changes represent
improved adherence to guidelines in 2011 compared to 2008, which may have contributed to the
lower readmission rate. This explanation relies on a closely linked inpatient and outpatient
population for generalizability to other hospitals; under health care reform this is likely to become
much more common.
With improved outpatient care of patients in 2011 it is possible that the risk of readmission in
certain patients decreased due to management of their overall health including comorbidities. In
the comparison of readmitted and not readmitted patients, diabetes was more prevalent among
readmitted patients in 2008, whereas this difference was not seen after the QI initiative in 2011.
This finding was supported by the regression analysis, which showed that the odds of readmission
were significantly greater among patients with diabetes in 2008, but not in 2011.

The QI

initiative through patient education, closer follow up and higher quality care could have led to
better management of diabetes and in doing so modified the risk of diabetes on readmission.
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However, there are at least two major limitations of this conclusion. First, an analysis of the
laboratory data such as hemoglobin A1C which would support the idea that diabetes control
improved was not performed. Second, with such few readmissions in 2011 it is possible that the
regression analysis did not have enough power to detect a significant increase in the odds of
readmission due to diabetes.

Previous studies have identified diabetes as a significant risk

predictor for readmission and the current CMS risk standardization model includes diabetes in
risk stratification; it does not include factors that are associated with quality of care. It is
important that the model continue to consider diabetes risk as these patients may still be more
likely to be readmitted over non-diabetics. It is encouraging that the specific risk attributable to
diabetes may potentially be responsive at least in part to QI initiatives.
A finding which highlights a potential shortfall of the initiative was that readmitted patients after
the initiative were more likely to have dementia (2008: 12.5%; 2011: 34.8%, p-value 0.035). The
percentage of not readmitted patients with dementia was roughly the same (11%) in both years as
was the percentage of all patients with dementia (2008: 11.7%; 2011: 10.1%). As there was a
significant decrease in the number of readmissions after the QI initiative, the data indicate that
readmissions were more often prevented in patients without dementia.

The finding in the

regression analysis of an increased odds of readmission for patients with dementia is most likely
the result of more patients without dementia being shifted into the not readmitted group.
Therefore, this finding should not be interpreted as a greater risk of readmission for dementia
patients after the initiative but rather that the UCHC initiative was less efficacious for patients
with dementia. Quality Improvement initiatives may require additional features to be more
helpful to this patient group.
There were other variables which were associated with readmission in 2008 but not in 2011. In
2008 an increased likelihood of readmission was observed in patients on aldosterone, discharged
with more services (SNF), and those who had an increased frequency of outpatient follow up in
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the 30 days following discharge from their initial hospitalization; a decreased likelihood of
readmission was found in patients on fewer medications at their initial admission.

There are

probably various reasonable explanations as to why these variables were associated with
readmission in 2008. For example, aldosterone may indicate a greater severity of HF; outpatient
follow up may have occurred after readmission, as the total number of outpatient visits within 30days after discharge were associated with readmission, whereas 7-day follow-ups were not; and
discharge with more services may indicate a sicker patient with greater readmission risk.
Therefore, it is most likely that these variables were not associated with readmission in 2011 due
to the limited ability of the regression analysis to detect an association, as there were fewer
readmissions. It is also possible that random variation may account for the differences here as
well. It is least likely that the association of these variables and readmissions changed due to an
effect of the QI initiative as their relationship with the initiative is not easily explainable.
Although it may have been the case, the results do not clearly show that patients readmitted in
2011 were sicker than those readmitted in 2008; however, patients readmitted despite the QI
initiative may have been more difficult to manage. The average number of follow up visits until
readmission in 2008 was 0.45, compared to 1.13 in 2011. Despite a significant increase in follow
up visits patients were still readmitted. This may indicate that patients readmitted after the QI
initiatives may require additional services; however, until readmission occurs it is unclear which
patients may require these services. Most patients readmitted in 2011 were discharged home with
VNA services after the initial hospitalization. In addition to the increased follow-up these
patients may presumably require more outpatient nursing care such as through a SNF.
Readmitted patients in 2011 were more likely to be discharged from rehospitalization on more
medications than readmitted patients in 2008. This may support the idea that readmitted patients
in 2011 were sicker and had indications for additional medications but it is also possible that there
was simply better guideline adherence in these patients at the time of readmission.
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There are several limitations to be considered in these analyses. First, this was a retrospective
review.

Therefore, the nature of the association between certain identified factors and

readmission cannot be clearly defined. Some variables may indeed be risk factors but this cannot
be determined by this type of study alone. Because this study involved chart abstraction of
previously documented data in the medical record, missing data could not be obtained. This
could have affected significance values of some of the variables and contributed to type II error.
Additionally, missing data resulted in the removal of several variables prior to satisfying
convergence criteria for the maximum regression model. It cannot be determined whether these
variables would have been influential on the final regression model had they remained as
potential covariates. In addition to there being fewer variables associated with readmission in
2011, there were also fewer readmissions and this may have diminished the ability to detect
associated factors (such as diabetes in the 2011 regression model). The sample size of the HF
population in 2008 and 2011 is also a limitation as a larger group may have identified additional
findings.

However, all hospitalizations and readmissions from both years were examined.

Patients readmitted to outside institutions were included among not readmitted patients in the
analyses; although an accurate readmission rate including readmissions to outside institutions was
provided by the Connecticut Hospital Association, data identifying which patients were
readmitted to outside institutions could not be provided. However, of 86 readmissions in both
years only 16 were to an outside institution.
In summary, this study shows that the 30-day all cause readmission rate after an initial
hospitalization for HF decreased 30% from 2008 to 2011 after the implementation of a hospitalwide QI initiative. Some trivial changes of little clinical significance were observed in the
inpatient HF population. The most notable change was a significant increase in outpatient follow
up since the start of the initiative which likely contributed the most to the lower readmission rate,
as increases in follow up were more apparent than any other difference between 2008 and 2011.
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Differences in the state of health of readmitted patients compared to not readmitted patients were
more easily identifiable in 2008 than in 2011. While the QI initiative might have been successful
at preventing readmission in patients, despite the severity of their illness or comorbidities, with
such few readmissions it is possible that a difference in 2011 was simply not detectable. It was,
however, evident that patients in 2011 may have been more difficult to manage as those
readmitted did have adequate follow-up.
The study also shows that although this QI initiative may have had a strong impact, there is still
room for improvement.

Particular attention is suggested for patients who are receiving

appropriate follow-up care after discharge but nonetheless are readmitted despite the initiative,
and for patients with dementia.
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Conclusion
Hospital readmissions, notably for HF, are a major burden on patients, families, health care
providers, and contribute to concern about the sustainability of the Medicare program. This study
shows that significant reductions in readmission rates can be achieved through a well-planned QI
initiative. As hospitals continue to respond to pressure to improve their quality of care, this
analysis suggests that a thorough and well-developed intervention can achieve notable decreases
in readmission after a hospitalization for heart failure. It also contributes an understanding of the
expected changes in HF patient characteristics, potential readmission risk predictors, and
improvements in follow up after a QI initiative is implemented. While readmission rates have
remained steady over the past decades, this study shows potential for a significant reduction as
hospitals nationwide are stimulated to implement similar initiatives.
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